Spineway Société Anonyme's (EPA:ALSPW) Shift From Loss To Profit

We feel now is a pretty good time to analyse Spineway Société Anonyme's (EPA:ALSPW) business as it appears the company may be on the cusp of a considerable accomplishment. Spineway Société Anonyme engages in the design, manufacture, and marketing of implant lines and surgical equipment for treating spinal column pathologies. The €45m market-cap company announced a latest loss of €14m on 31 December 2020 for its most recent financial year result. As path to profitability is the topic on Spineway Société Anonyme's investors mind, we've decided to gauge market sentiment. We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.

See our latest analysis for Spineway Société Anonyme

Spineway Société Anonyme is bordering on breakeven, according to some French Medical Equipment analysts. They anticipate the company to incur a final loss in 2022, before generating positive profits of €2.1m in 2023. The company is therefore projected to breakeven around 2 years from today. In order to meet this breakeven date, we calculated the rate at which the company must grow year-on-year. It turns out an average annual growth rate of 88% is expected, which is rather optimistic! Should the business grow at a slower rate, it will become profitable at a later date than expected.

We're not going to go through company-specific developments for Spineway Société Anonyme given that this is a high-level summary, though, take into account that typically a high forecast growth rate is not unusual for a company that is currently undergoing an investment period.

One thing we’d like to point out is that The company has managed its capital judiciously, with debt making up 27% of equity. This means that it has predominantly funded its operations from equity capital, and its low debt obligation reduces the risk around investing in the loss-making company.

Next Steps:

There are key fundamentals of Spineway Société Anonyme which are not covered in this article, but we must stress again that this is merely a basic overview. For a more comprehensive look at Spineway Société Anonyme, take a look at Spineway Société Anonyme's company page on Simply Wall St. We've also put together a list of pertinent factors you should look at:

1. Historical Track Record: What has Spineway Société Anonyme's performance been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Spineway Société Anonyme's board and the CEO’s background.
3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

If you’re looking to trade Spineway Société Anonyme, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
^*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.